Proteasome immunosubunits protect against the development of CD8 T cell-mediated autoimmune diseases

Journal of Immunology

Volumn 187, Issue 5, 2011, Pages 2302-2309

  Zaiss, Dietmar M W ^a   Bekker, Cornelis P J ^a   Gröne, Andrea ^a   Lie, Benedicte A ^b   Sijts, Alice J A M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR MASS POLYPEPTIDE 7; MULTICATALYTIC ENDOPEPTIDASE COMPLEX LIKE 1; POLYPEPTIDE; PROTEASOME; PROTEASOME IMMUNOSUBUNIT; PROTEINASE; RAG1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DIABETOGENESIS; DISEASE PREDISPOSITION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC RISK; HAPLOTYPE; HLA TYPING; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; IRRADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MICE; MICE, KNOCKOUT; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEASOME ENDOPEPTIDASE COMPLEX; RISK FACTORS;

EID: 80052679971     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101003     Document Type: Article

References (34)

1. Yewdell, J. W., E. Reits, and J. Neefjes. 2003. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat. Rev. Immunol. 3: 952-961. (Pubitemid 37521537)
2. Kloetzel, P. M. 2001. Antigen processing by the proteasome. Nat. Rev. Mol. Cell Biol. 2: 179-187.
3. Sijts, A., D. Zaiss, and P. M. Kloetzel. 2001. The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: implications for vaccine design. Curr. Mol. Med. 1: 665-676. (Pubitemid 33772942)
4. Toes, R. E., A. K. Nussbaum, S. Degermann, M. Schirle, N. P. Emmerich, M. Kraft, C. Laplace, A. Zwinderman, T. P. Dick, J. Müller, et al. 2001. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J. Exp. Med. 194: 1-12. (Pubitemid 32660433)
5. Sijts, E. J., and P. M. Kloetzel. 2011. The role of the proteasome in the generation of MHC class I ligands and immune responses. Cell. Mol. Life Sci. 68: 1491-1502.
6. Chen, W., C. C. Norbury, Y. Cho, J. W. Yewdell, and J. R. Bennink. 2001. Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med. 193: 1319-1326. (Pubitemid 32524782)
7. Deol, P., D. M. Zaiss, J. J. Monaco, and A. J. Sijts. 2007. Rates of processing determine the immunogenicity of immunoproteasome-generated epitopes. J. Immunol. 178: 7557-7562. (Pubitemid 46898024)
8. Nussbaum, A. K., M. P. Rodriguez-Carreno, N. Benning, J. Botten, and J. L. Whitton. 2005. Immunoproteasome-deficient mice mount largely normal CD8+ T cell responses to lymphocytic choriomeningitis virus infection and DNA vaccination. J. Immunol. 175: 1153-1160. (Pubitemid 41095002)
9. Seifert, U., L. P. Bialy, F. Ebstein, D. Bech-Otschir, A. Voigt, F. Schröter, T. Prozorovski, N. Lange, J. Steffen, M. Rieger, et al. 2010. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 142: 613-624.
10. Nejentsev, S., J. M. Howson, N. M. Walker, J. Szeszko, S. F. Field, H. E. Stevens, P. Reynolds, M. Hardy, E. King, J. Masters, et al Wellcome Trust Case Control Consortium. 2007. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450: 887-892. (Pubitemid 350231332)
11. Friese, M. A., and L. Fugger. 2009. Pathogenic CD8(+) T cells in multiple sclerosis. Ann. Neurol. 66: 132-141.
12. Friese, M. A., K. B. Jakobsen, L. Friis, R. Etzensperger, M. J. Craner, R. M. McMahon, L. T. Jensen, V. Huygelen, E. Y. Jones, J. I. Bell, and L. Fugger. 2008. Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nat. Med. 14: 1227-1235.
13. Pinkse, G. G., O. H. Tysma, C. A. Bergen, M. G. Kester, F. Ossendorp, P. A. Van Veelen, B. Keymeulen, D. Pipeleers, J. W. Drijfhout, and B. O. Roep. 2005. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc. Natl. Acad. Sci. USA 102: 18425-18430. (Pubitemid 43011242)
14. Caudill, C. M., K. Jayarapu, L. Elenich, J. J. Monaco, R. A. Colbert, and T. A. Griffin. 2006. T cells lacking immunoproteasome subunits MECL-1 and LMP7 hyperproliferate in response to polyclonal mitogens. J. Immunol. 176: 4075-4082. (Pubitemid 44264386)
15. Eike, M. C., T. Becker, K. Humphreys, M. Olsson, and B. A. Lie. 2009. Conditional analyses on the T1DGC MHC dataset: novel associations with type 1 diabetes around HLA-G and confirmation of HLA-B. Genes Immun. 10: 56-67.
16. Di Lorenzo, T. P., M. Peakman, and B. O. Roep. 2007. Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes. Clin. Exp. Immunol. 148: 1-16. (Pubitemid 46364983)
17. Heap, G. A., and D. A. Van Heel. 2009. The genetics of chronic inflammatory diseases. Hum. Mol. Genet. 18(R1): R101-R106.
18. DiLorenzo, T. P., R. T. Graser, T. Ono, G. J. Christianson, H. D. Chapman, D. C. Roopenian, S. G. Nathenson, and D. V. Serreze. 1998. Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement. Proc. Natl. Acad. Sci. USA 95: 12538-12543.
19. Hayashi, T., and D. Faustman. 1999. NOD mice are defective in proteasome production and activation of NF-kappaB. Mol. Cell. Biol. 19: 8646-8659. (Pubitemid 30414057)
20. Hensley, S. E., D. Zanker, B. P. Dolan, A. David, H. D. Hickman, A. C. Embry, C. N. Skon, K. M. Grebe, T. A. Griffin,W. Chen, et al. 2010. Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses. J. Immunol. 184: 4115-4122.
21. Zaiss, D. M., N. De Graaf, and A. J. Sijts. 2008. The proteasome immunosubunit multicatalytic endopeptidase complex-like 1 is a T-cell-intrinsic factor influencing homeostatic expansion. Infect. Immun. 76: 1207-1213. (Pubitemid 351428083)
22. Groettrup, M., C. J. Kirk, and M. Basler. 2010. Proteasomes in immune cells: more than peptide producers? Nat. Rev. Immunol. 10: 73-78.
23. Turley, S., L. Poirot, M. Hattori, C. Benoist, and D. Mathis. 2003. Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J. Exp. Med. 198: 1527-1537. (Pubitemid 37467167)
24. Kim, H. S., M. S. Han, K. W. Chung, S. Kim, E. Kim, M. J. Kim, E. Jang, H. A. Lee, J. Youn, S. Akira, and M. S. Lee. 2007. Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. Immunity 27: 321-333. (Pubitemid 47284922)
25. Krupica, T., Jr., T. J. Fry, and C. L. Mackall. 2006. Autoimmunity during lymphopenia: a two-hit model. Clin. Immunol. 120: 121-128.
26. Guerau-de-Arellano, M., M. Martinic, C. Benoist, and D. Mathis. 2009. Neonatal tolerance revisited: a perinatal window for Aire control of autoimmunity. J. Exp. Med. 206: 1245-1252.
27. Fehling, H. J., W. Swat, C. Laplace, R. Kühn, K. Rajewsky, U. Müller, and H. Von Boehmer. 1994. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265: 1234-1237. (Pubitemid 24291982)
28. De Graaf, N., M. J. Van Helden, K. Textoris-Taube, T. Chiba, D. J. Topham, P. M. Kloetzel, D. M. Zaiss, and A. J. Sijts. 2011. PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I-binding peptides in vivo. Eur. J. Immunol. 41: 926-935.
29. Han, B., P. Serra, A. Amrani, J. Yamanouchi, A. F. Marée, L. Edelstein-Keshet, and P. Santamaria. 2005. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide. Nat. Med. 11: 645-652. (Pubitemid 40868305)
30. Karges, W., T. Rajasalu, A. Spyrantis, A. Wieland, B. Boehm, and R. Schirmbeck. 2007. The diabetogenic, insulin-specific CD8 T cell response primed in the experimental autoimmune diabetes model in RIP-B7.1 mice. Eur. J. Immunol. 37: 2097-2103. (Pubitemid 47250202)
31. Brosi, H., M. Reiser, T. Rajasalu, A. Spyrantis, F. Oswald, B. O. Boehm, and R. Schirmbeck. 2009. Processing in the endoplasmic reticulum generates an epitope on the insulin A chain that stimulates diabetogenic CD8 T cell responses. J. Immunol. 183: 7187-7195.
32. Harlan, D. M., H. Hengartner, M. L. Huang, Y. H. Kang, R. Abe, R. W. Moreadith, H. Pircher, G. S. Gray, P. S. Ohashi, G. J. Freeman, et al. 1994. Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc. Natl. Acad. Sci. USA 91: 3137-3141.
33. Sakamoto, K., T. Imamura, F. Niwa, S. Komori, Y. Ishihara, K. Shiga, M. Ito, and H. Hosoi. 2011. Dermatomyositis developed in a recipient of allogeneic BMT; the differentiation of chronic GVHD and autoimmune disease. Bone Marrow Transplant.
34. Narita, A., H. Muramatsu, Y. Takahashi, H. Sakaguchi, S. Doisaki, N. Nishio, A. Hama, A. Shimada, M. Ito, and S. Kojima. 2011. Autoimmune-like hepatitis following unrelated BMT successfully treated with rituximab. Bone Marrow Transplant.